Blog
aduross
aduross
January 11, 2021

Introducing new Vineti PTM® flexibility features: next-gen label printing and rescheduling innovations deliver critical workflow options that advanced therapies require

Introducing new Vineti PTM® flexibility features: next-gen label printing and rescheduling innovations deliver critical workflow options that advanced therapies require...

January 4, 2021

The Vineti Alliance Network — a preview of what’s next

For Vineti, 2020 has been all about continuing to deliver progress for advanced therapies, even amid an unpredictable year. One...

November 17, 2020

Now is the time for proven technology that drives scale

A Vineti technology perspective from CEO and Co-founder Amy DuRoss   The underlying medical science behind cell and gene therapies continues...

October 13, 2020

Vineti Extends Series C Funding Round to $68M with an Expanded Investor Coalition

Today, we’re very excited and honored to announce the extension of our Series C round of funding. We’ve expanded the...

October 7, 2020

Crispr’s Nobel Moment

“Crispr — overrated or underrated?” At this month’s CBInsights Future of Health conference, I had the good fortune to do a live...

August 17, 2020

Vineti Announces New Chief Commercial Officer

Proven biotech/pharma executive and advanced therapies pioneer Joe DePinto brings extensive commercial expertise to the industrialization of cell and gene...

June 16, 2020

Announcing our new enterprise-grade Alliance Network — and a collaboration with Mavens — to further industrialize cell and gene therapies

Today, I’m really excited to share more progress from Vineti. We’ve launched the new Vineti Alliance Network to deliver an enterprise-grade approach...

June 8, 2020

Team Vineti stands in solidarity with the Black community: Black Lives Matter

Our company was founded in 2016 to bring life to the following vision: “Vineti works to create a world where individualized,...

May 28, 2020

Cell and gene therapy — a dose of good news

Cancer, serious genetic disorders, and other pressing health conditions never stop. Neither does cell and gene therapy. And that’s great...

May 5, 2020

Vineti announces new executive team members

Today, Vineti, Inc., the provider of the leading digital platform of record for personalized therapeutics, is very pleased to share...

March 2, 2020

Continuing operations safely during coronavirus

At our core, Vineti is a technology company focused on health, well-being, and patient safety. Our software platform manages critical...

January 15, 2020

Vineti Announces New Board of Directors Member

SAN FRANCISCO, January 15, 2020 — Vineti, Inc., the provider of the leading digital platform of record for personalized therapeutics,...